Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results Biotech Investing
Cerecor Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017 Pharmaceutical Investing
Mustang Bio Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights Biotech Investing
Reata Announces Kyowa Hakko Kirin Received SAKIGAKE Priority Review Designation for Bardoxolone Methyl in Japan Pharmaceutical Investing
Ovid Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Progress Biotech Investing
3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL(TM) Test for Hodgkin’s Lymphoma Genetics Investing
